Satoshi Hashigaki

Satoshi Hashigaki

UNVERIFIED PROFILE

Are you Satoshi Hashigaki?   Register this Author

Register author
Satoshi Hashigaki

Satoshi Hashigaki

Publications by authors named "Satoshi Hashigaki"

Are you Satoshi Hashigaki?   Register this Author

17Publications

298Reads

26Profile Views

Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.

Breast Cancer 2019 09 24;26(5):637-650. Epub 2019 May 24.

Department of Breast Oncology, Aichi Cancer Center Hospital, 1-1, Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-019-00970-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694088PMC
September 2019

Correction to: Neutropenia management with palbociclib in Japanese patients with advanced breast cancer.

Breast Cancer 2019 09;26(5):651

Kyoto University Graduate School of Medicine, 54 Kawaracho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12282-019-00984-1DOI Listing
September 2019

Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settings.

Jpn J Clin Oncol 2019 Jul;49(7):676-686

Graduate School of Medicine, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jjco/hyz049DOI Listing
July 2019

Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung Cancer.

Cancer Res Treat 2018 Jul 6;50(3):691-700. Epub 2017 Jul 6.

State Key Laboratory of South China, Hong Kong Cancer Institute and The Chinese University of Hong Kong, Shatin, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2017.280DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056984PMC
July 2018

Efficacy and safety of monotherapy by pegvisomant, a growth hormone receptor antagonist, in Japanese patients with acromegaly.

Endocr J 2016 Apr 20;63(4):337-47. Epub 2016 Jan 20.

National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1507/endocrj.EJ15-0619DOI Listing
April 2016

Phase I study of sunitinib plus S-1 and cisplatin in Japanese patients with advanced or metastatic gastric cancer.

Invest New Drugs 2014 Apr 12;32(2):261-70. Epub 2013 May 12.

Department of Clinical Oncology, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-013-9948-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945293PMC
April 2014

Phase I study of sunitinib plus modified FOLFOX6 in Japanese patients with treatment-naive colorectal cancer.

Anticancer Res 2012 Mar;32(3):973-9

6-5-1, Kashiwanoha, National Cancer Center Hospital East, Department of Gastroenterology and Gastrointestinal Oncology, Kashiwa, Chiba 277-8577, Japan.

View Article

Download full-text PDF

Source
March 2012